InvestorsHub Logo
Followers 376
Posts 17085
Boards Moderated 4
Alias Born 03/07/2014

Re: Disbelief1 post# 99558

Wednesday, 03/06/2019 9:22:45 AM

Wednesday, March 06, 2019 9:22:45 AM

Post# of 106839
$USRM: CEO, Comella AND USRM UNDER SEC INVESTIGATION....

Uh...make that FORMAL SEC INVESTIGATION w/ subpoenas issued...several now per their own SEC filings....


10-Q: SEC SUBPOENA TO Tomas and Comella AS INDIVIDUALS....

The most recent 10-Q on file for USRM is a FREAKING TRAIN WRECK 20 ways to Sunday if you ask me...BIGGER LOSSES...GROWING CURRENT AND LONG TERM LIABILITIES and most important...MASSIVELY EXPLODING SG&A COSTS...aka SALARIES and LEGAL FEES for the most part....INSIDERS and ATTORNEYS get wealthy while shareholders get the screw-job...

99% LOSSES to the common shares "on the watch" of Tomas and Comella...AKA "THE TWO"....who also side-gig all over the place....NOT EVEN acting as full-time CEO and CSO of this mess..and WHERE IS THEIR 95 YEAR OLD CHAIRMAN OF THE BOARD and actual "real" board of directors...who would have FIRED THESE TWO for the massive losses....DEPARTMENT OF JUSTICE LAWSUIT and now FORMAL SEC INVESTIGATION.....

They are literally CRUMBLING...MASSIVE LOSSES...no bills being paid..common stock being issued to pay common bills.. EXPLOSIVE increase in their SG&A cost line which is why the MASSIVE LOSS INCREASE.....

BUT MOST IMPORTANT IMO...is the sham-wow Tomas special called GACP let Comella go...and AMERICAN STEM CELL CENTERS OF EXCELLENCE IS NO MORE....which 100% tells me GACP considers this company and Comella as TOXIC and cut their ties to them...NO CLINICS WILL BE OPENED (LOL) like who didn't see that coming...ANOTHER Tomas CLASSIC SERIES....

AND THE SEC issued additional SUBPOENAS TO BOTH CEO Tomas and to CSO Kristy Kristin Comella AS INDIVIDUALS...which means the SEC IS DEADLY SERIOUS and their INVESTIGATION is 100% LIVE and on-going....this will NOT END WELL....


In order for the SEC to get to a point to issue subpoenas and FORMALLY INVESTIGATE A COMPANY and especially a CEO and CSO...aka Sr company officers as individuals...the SEC INVESTIGATORS MUST PRESENT THEIR CASE TO A "Sr SEC REVIEW COMMITTEE" who gives a YES/NO to allowing subpoena power to the SEC investigators based on the merits of the case and issues they present....

The FLORIDA SEC FIELD OFFICE WAS GRANTED NOT ONCE...but now TWICE...subpoena power to investigate the company U.S. Stem Cell Inc and now to FORMALLY INVESTIGATE CEO Mike Miguel Tomas and CSO Kristen Comella as individuals...asking for among other things emails and various communications sent or received by them...

BUYER BEWARE IMO....THE SEC DOES NOT willy-nilly open FORMAL INVESTIGATIONS...they are very low on resources and short handed and ONLY go after the most serious and egregious violators in most cases..
https://www.sec.gov/Archives/edgar/data/1388319/000118518518001385/usstem20180630_10q.htm

JUST ISSUED DISASTER OF A 10-Q, PAGE 40:

"On or about March 1, 2018, the U.S. Securities and Exchange Commission (“Commission”), Miami Regional Office (“Commission Staff”), served a subpoena upon U.S. Stem Cell, Inc., which seeks the production of certain documents and communications. The Commission Staff is conducting a formal non-public, fact-finding inquiry of U.S. Stem Cell, Inc (“Investigation”). The Investigation is neither an allegation of wrongdoing nor a finding that any violation of law has occurred. The Company is cooperating with, and has provided information and documents to, the Commission Staff. As part of the Investigation, on or about May 14, 2018, the Commission Staff served subpoenas upon Kristin Comella and Mike Tomas, respectively, seeking the production of certain documents and communications. Ms. Comella and Mr. Tomas responded to the respective subpoenas and provided information and documents to the Commission Staff. At this juncture, the Company is not able to predict the duration, scope, results, or consequences of the Commission Staff’s investigation. There can be no assurance that the Investigation will be resolved in a manner that is not adverse to the Company.
"

2.5 MONTHS after the SEC started a formal investigation they then SUBPOENA CEO Tomas and CSO Comella AS INDIVIDUALS..BAMMO...SEC IS NOW DOGGING Tomas as CEO and Comella as CSO...AS INDIVIDUALS...making um produce documents and communications...IN ADDITION TO THE USRM "company" SUBPOENA already received...that kicked-off the entire SEC FORMAL INVESTIGATION....

They're COOKED and FRIED IF YOU ASK ME....I'd expect CHARGES TO BE FILED SOON....real...real...SOON HERE....and SHAZAM...another Tomas PERFECTLY TIMED P&D RIGHT WHEN THE SEC 10-Q IS COMING OUT...just like ALL THE PRIOR TIMES HE's done it....LIKE A SWISS WATCH it's so perfectly timed....

Now comes the "D" for DUMP in that P&D as this train wreck of a 10-Q shows that NOTHING HAS CHANGED...it's only GETTING WORSE...BIGGER LOSSES...NON PAID BILLS..BIGGER TOTAL AND CURRENT LIABILITIES..ISSUING SHARES STILL....GOING CONCERN STILL and on and on and on....just a BAD BROKEN RECORD REPLAY but the needle is wearing out.....


BREAKING ROCKS IN THE HOT SUN....LOL.....



AND the civil lawsuits rage on....the USRM/Comella little rogue clinic biz will become un-insurable IMO or will pay premiums SKY HIGH for losing so many cases and causing payouts to plaintiffs....

INSURANCE COMPANIES AREN'T IN THE BIZ OF MAKING 7 FIGURE LOSS PAYMENTS FOR STUPID SHIT done by bad actors as FDA Commissioner Scott Gottlieb labeled Comella and USRM and gang....AND....AND...as of the last SEC FILING...Tomas HAD NOT yet even paid the $100K PORTION OF THEIR LOSS/DEDUCTIBLE for their prior blinded ladies payouts- and now they have another suit in the hopper against them.....




https://www.pacermonitor.com/public/case/24475300/United_States_of_America_v_US_Stem_Cell_Clinic,_LLC_et_al

Oh...and the United States attorneys...the DOJ...is SUING THEM TOO...LOL..yeah....like what the hell can possibly go wrong with this bad train wreck......SEC...DOJ....CIVIL SUITS...99% LOSSES to the common stock....LOL....heck yeah.....

Posts are only my amateur opinions, personal views and thoughts. They are not any type of investment advice. Do one's own due diligence.